Navigation Links
C3i Teams with Oracle's Health Sciences Global Business Unit to Provide Customers with Clinical Training and Support Services

BOSTON, June 24 /PRNewswire/ -- C3i, the leader in global training and support for clinical electronic data capture software, announced today that it will team with Oracle's new Health Sciences Global Business Unit to provide joint customers with clinical training and support services. Separately, C3i also announced the expansion of its Sofia, Bulgaria clinical support operations center.

C3i will play an important role in the ecosystem of the Oracle Health Sciences Global Business Unit. The company will provide both web based and classroom training, 7x24 multi-lingual help desk, user/application administration, global hardware provisioning and technical site assessments to sponsors and clinical research organizations using Oracle's best-in-class clinical applications.

"Over the last three years, C3i has developed a suite of high-quality services to support Oracle's clinical software deployments," said Nick Giannasi, Senior Director, Oracle Health Sciences Global Business Unit. "C3i's teams are currently serving many of our worldwide clinical customers and their global delivery complements Oracle's clinical trial management applications."

In support of the growth of clinical trials worldwide -- and of Oracle customers in particular -- C3i has significantly increased its global capabilities. "Our multi-lingual call center in Sofia, Bulgaria has grown to over 200 people in just two years, and is currently supporting 11,000 sites in 20 languages." observes Jean-Christophe Muyl, General Manager of C3i's Clinical Services.

In addition to Bulgaria, C3i has call centers in Hyderabad, India and Wilkes-Barre, Pennsylvania; plus a global hardware provisioning center in Denville, New Jersey, which currently ships laptops across the globe.

"Our rapid growth from niche North American company to a leader in global clinical support services has been fueled by the increasing importance of clinical trials and the development of transformational technology by companies like Oracle," said Joel Morse, CEO of C3i.

Alastair Clewlow, Head of Clinical Data & Document Management at LEO Pharma, a Danish pharmaceutical manufacturer, offered his perspective as a joint-customer of Oracle and C3i: "LEO has realized significant gains in the efficiency of our clinical data management since our adoption of Oracle Remote Data Capture software. A key partner in this effort with us has been C3i. C3i's multi-lingual help desk and other related services have allowed us to focus on the execution of our trials while ensuring high customer satisfaction among the investigators who need technical help. As a customer, we see great value in Oracle's increasing focus on the clinical development process. Their close relationship with C3i offers more proof of their commitment to our success."

C3i, a member of the Oracle(R) PartnerNetwork, is participating in this week's Drug Industry Association's Annual Meeting in Boston, Massachusetts.

About C3i: Headquartered in Morristown, New Jersey, C3i Inc. has global operations in the United States, India and Bulgaria. Their 750 employees provide systems implementation, technology training, multi-lingual help desk, hardware provisioning, and break/fix, asset management, and user/application administration services for pharmaceutical sales and clinical professionals worldwide. To learn more, visit .

Oracle is a registered trademark of Oracle Corporation and/or its affiliates.


Dave Hanaman



Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Touch Bionics adds to sales, marketing, production and design teams
2. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
3. Masada Teams With Leading Waste Management Firm to Produce Ethanol From Municipal Solid Waste in the Dominican Republic
4. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
5. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
6. Instrumentation Laboratory Ships 1000th GEM Premier 4000 Analyzer to Scripps Health
7. Premier Healthcare Alliance Honors Siemens Healthcare Diagnostics for Excellence in Supplier Performance
8. Concuity Announces Partnership with Financial Healthcare Systems, LLC
9. InterMune to Present at Jefferies Healthcare Conference
10. 17th Annual Congress on Womens Health To Be Held March 27-29, 2009 in Collaboration with American Medical Womens Association (AMWA)
11. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading supplier of ... has promoted Melanie Aregger to serve as Chief Operating Officer. , Having ... management team and was promoted to Head of InSphero Diagnostics in 2014. ...
(Date:11/24/2015)... 24, 2015 HemoShear Therapeutics, LLC, a ... for metabolic disorders, announced today the appointment of ... of Directors (BOD). Mr. Watkins is the former ... Sciences (HGS), and also served as the chairman ... Powers , Chairman and CEO of HemoShear Therapeutics. ...
(Date:11/24/2015)... YORK , Nov. 24, 2015 According to ... than in 2005. This is something that many doctors, scientists, ... time. One questions remains: with fewer PSA tests being done, ... ? Dr. David Samadi, "Despite the ... the disease remains the second leading cancer cause of death ...
(Date:11/23/2015)... ... November 23, 2015 , ... ... development of its Nexera UC Unified Chromatography system. The award from R&D magazine ... new products of the year in the analytical and testing category. R&D Magazine ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):